Showing results 6911 to 6930 of 14621
< previous
next >
| Preview | Issue Date | Title | Author(s) |
| 2013 | Imaging coronary atherosclerosis: is there space for magnetic resonance imaging? | Andrews, J.; Nicholls, S. |
| 2018 | Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data | Román, L.S.; Menon, B.K.; Blasco, J.; Hernández-Pérez, M.; Dávalos, A.; Majoie, C.B.L.M.; Campbell, B.C.V.; Guillemin, F.; Lingsma, H.F.; Anxionnat, R.; Epstein, J.; Saver, J.L.; Marquering, H.A.; Wong, J.H.; Lopes, D.K.; Reimann, G.; Desal, H.; Dippel, D.W.J.; Coutts, S.; du Mesnil de Rochemont, R.; et al. |
| 2019 | Imaging genetically-modified cells with a miniaturised multimodal optical coherence tomography + fluorescence probem | Li, J.; Quirk, B.C.; Delhove, J.; Kirk, R.; Mc Carron, A.; Cmielewski, P.; Boudoux, C.; Parsons, D.; Donnelley, M.; McLaughlin, R.A.; IEEE Photonics Conference (IPC) (29 Sep 2019 - 3 Oct 2019 : San Antonio, USA) |
| 2014 | Imaging of atherosclerotic plaques in obesity: Excessive fat accumulation, plaque progression and vulnerability | Kataoka, Y.; Nicholls, S. |
| 2014 | Imaging of skin birefringence for human scar assessment using polarization-sensitive optical coherence tomography aided by vascular masking | Gong, P.; Chin, L.; Es'Haghian, S.; Liew, Y.; Wood, F.; Sampson, D.; McLaughlin, R. |
| 2009 | Imaging of the haemorrhagic complications of the haemophilias | Constantine, S.; Buckley, J.; Heysen, J. |
| 2007 | Imaging of the haemorrhagic complications of the haemophilias: a review | Constantine, S.; Buckley, J.; Heysen, J.; 2007 Royal Australian and New Zealand College of Radiologists Annual Scientific Meeting (4 Oct 2007 - 7 Oct 2007 : Melbourne, Victoria) |
| 2013 | Imaging progression of coronary atherosclerosis: Lessons learned and ongoing challenges | Nicholls, S.; Andrews, J.; Puri, R.; Uno, K.; Kataoka, Y. |
| 2017 | Imaging protective mast cells in living mice during severe contact hypersensitivity | Reber, L.L.; Sibilano, R.; Starkl, P.; Roers, A.; Grimbaldeston, M.A.; Tsai, M.; Gaudenzio, N.; Galli, S.J. |
| 2003 | Imaging pulmonary gene expression with positron emission tomography | Richard, J.; Zhou, Z.; Ponde, D.; Dence, C.; Factor, P.; Reynolds, P.; Luker, G.; Sharma, V.; Ferkol, T.; Piwnica-Worms, D.; Schuster, D. |
| 2003 | Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia | O'Brien, S.; Guilhot, F.; Larson, R.; Gathmann, I.; Baccarani, M.; Cervantes, F.; Cornelissen, J.; Fischer, T.; Hochhaus, A.; Hughes, T.; Lechner, K.; Nielsen, J.; Rousselot, P.; Reiffers, J.; Saglio, G.; Shepherd, J.; Simonsson, B.; Gratwohl, A.; Goldman, J.; Kantarjian, H.; et al. |
| 2007 | Imatinib increases the intracellular concentration of nilotinib which may explain the observed synergy between these drugs | White, D.; Saunders, V.; Quinn, S.; Manley, P.; Hughes, T. |
| 2005 | Imatinib inhibits the functional capacity of cultured human monocytes | Dewar, A.; Doherty, K.; Hughes, T.; Lyons, A. |
| 2003 | Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors | Dewar, A.; Domaschenz, R.; Doherty, K.; Hughes, T.; Lyons, A. |
| 2012 | Imatinib mesylate at therapeutic doses has no impact on folliculogenesis or spermatogenesis in a leukaemic mouse model | Schultheis, B.; Nijmeijer, B.; Yin, H.; Gosden, R.; Vaz de Melo, J. |
| 2003 | Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase | Branford, S.; Rudzki, Z.; Harper, A.; Grigg, A.; Taylor, K.; Durrant, S.; Arthur, C.; Browett, P.; Schwarer, A.; Ma, D.; Seymour, J.; Bradstock, K.; Joske, D.; Lynch, K.; Gathmann, I.; Hughes, T. |
| 2009 | Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1 | Chase, A.; Schultheis, B.; Kreil, S.; Baxter, J.; Hidalgo-Curtis, C.; Jones, A.; Zhang, L.; Grand, F.; Vaz de Melo, J.; Cross, N. |
| 2011 | Imatinib trough levels in chronic myelogenous leukemia: does one dose fit all? | Yeung, D.T.; White, D.L. |
| 2014 | Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors | Zuurbier, L.; Gutierrez, A.; Mullighan, C.G.; Cante-Barrett, K.; Gevaert, A.O.; de Rooi, J.; Li, Y.; Smits, W.K.; Buijs-Gladdines, J.G.; Sonneveld, E.; Look, A.T.; Horstmann, M.; Pieters, R.; Meijerink, J.P. |
| 2002 | Immediate and long-term results of radiofrequency ablation of pulmonary vein ectopy for cure of paroxysmal atrial fibrillation using a focal approach | Sanders, P.; Morton, J.; Deen, V.; Davidson, N.; Sparks, P.; Vohra, J.; Kalman, J. |
